Oral peptide combinations for prostate symptoms in Agent Orange-exposed veterans
Observational study · 2012
- What was studied
- 150 veterans with benign prostatic hyperplasia. The same 150 are shown before and after treatment.
- Main finding
- In 150 veterans, mean prostate symptom score (IPSS) fell from 20.94 to 8.46 (p<0.01) and urinary flow increased from 4.9 to 9.1 mL/s (p<0.001). This before-and-after comparison tested four oral products together.
International Prostate Symptom Score · 20.94 ± 8.49 → 8.46 ± 2.78 · p<0.01
Related evidence maps: Military & occupational ↗
Reported findings and study design
Prospective, within-person comparison of urinary symptoms, quality of life and urine flow before and after adjunctive treatment. All reported denominators below are 150 at each assessment.
Population or model 150 veterans with benign prostatic hyperplasia. The same 150 are shown before and after treatment.
Dose, route and schedule
The 20-day oral regimen lists Veziliut, Vezugen, Kristagen and Ventfort at 0.2 g each per day. These are amounts of the named products. The paper gives no purified peptide content.
Protocol source ↗ · Original journal PDF, methods and Tables 1–3. Parent program report and Ministry of Defence project citation checked.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| International Prostate Symptom Score | 20.94 ± 8.49 → 8.46 ± 2.78 | p<0.01 |
| Urinary flow | 4.9 ± 2.3 → 9.1 ± 2.5 mL/s | p<0.001 |
| Urinary symptom quality-of-life item | 4.10 ± 1.01 → 2.53 ± 0.61 | p<0.001 |
| Severe urinary symptoms | 61/150 → 14/150 | IPSS ≥20. The paper reports 40.7% → 9.3%. |
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- There was no concurrent untreated comparator or single-product arm. The results cover the combination.
- The tested Veziliut lot and its peptide content remain unclear. The two 150-person publications are part of the same parent program, and participant overlap remains unverified.
Related publications may describe some of the same participants or experiments.
Source details
Original journal PDF, methods and Tables 1–3. Parent program report and Ministry of Defence project citation checked.
Sources checked
Citation
Hoàng Văn Huấn, Phạm Khắc Linh, Nguyễn Như Nghĩa, and colleagues. Oral peptide combinations for prostate symptoms in Agent Orange-exposed veterans Journal of Tropical Science and Technology. 2012;(1):85–93.
Related compounds
Ventfort
A peptide mixture extracted from animal aorta, described in Russian reports on blood vessels and in dental patent cases.
Vesugen
A synthetic three-amino-acid peptide (Lys–Glu–Asp, or KED) studied in vascular and cell-aging research.
Crystagen
A short-peptide product described in institute reports as containing glutamate, aspartate and proline. The reports do not establish that the tested product was chemically identical to isolated Glu–Asp–Pro (EDP).